Trial intelligence / Profile preview

A Pilot Study of [18F]-CP18 PET/CT Imaging in Ovarian, Peritoneal, or Fallopian Tube Cancers

NCT01766622Phase 2Withdrawn

Sponsor
National Institutes of Health
Start
Nov 2012
Primary completion
Jul 2013
Modality
Peptides
01

Overview

A Phase 2 trial of [18F]-CP18 in ovarian cancer, primary peritoneal cancer (PPC), fallopian tube cancer (PFTC), sponsored by National Institutes of Health. Planned start Nov 2012; status: withdrawn.

02

Drugs

[18F]-CP18
03

Conditions

ovarian cancerprimary peritoneal cancer (PPC)fallopian tube cancer (PFTC)

Beyond the preview

Go deeper on NCT01766622.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01766622.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call